Davenport & Co’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,867
| Closed | -$218K | – | 1181 |
|
|
2025
Q1 | $218K | Buy |
+1,867
| New | +$218K | ﹤0.01% | 1082 |
|
|
2024
Q2 | – | Sell |
-5,817
| Closed | -$464K | – | 1083 |
|
|
2024
Q1 | $464K | Buy |
5,817
+2,000
| +52% | +$160K | ﹤0.01% | 812 |
|
|
2023
Q4 | $304K | Buy |
+3,817
| New | +$304K | ﹤0.01% | 886 |
|
|
2023
Q1 | – | Sell |
-14,200
| Closed | -$1.1M | – | 1026 |
|
|
2022
Q4 | $1.1M | Buy |
+14,200
| New | +$1.1M | 0.01% | 476 |
|
|
2020
Q1 | – | Sell |
-2,300
| Closed | -$238K | – | 669 |
|
|
2019
Q4 | $238K | Buy |
+2,300
| New | +$238K | ﹤0.01% | 636 |
|